DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

The DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award, supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Key features of this award include: • Potential impact and innovation are important features of the TIA • Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis • The strength of the application should rely on the approach • The award supports research in the area of ALS drug or therapy discovery • The program is sponsored by the Department of Defense, Dept. of the Army -- USAMRAA